Pharmaceuticals

Biotech Ingredient Market Expected to Reach $87.06 Billion by 2030 at 6.6% CAGR

March 18, 2026March 18, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Biotech Ingredient Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The biotech ingredient market size has experienced robust growth in recent years. It is projected to expand from $63.25 billion in 2025 to $67.42 billion in 2026, at a compound annual growth rate (CAGR) of 6.6%. The historical period’s growth can be attributed to several factors, including an escalating demand for natural and safe ingredients, advancements in microbial fermentation technologies, increasing awareness of biotech applications in food and personal care, a rising consumer preference for sustainable ingredients, and the early adoption of yeast- and algae-based compounds.

The biotech ingredient market size is projected for robust expansion over the coming years, set to reach $87.06 billion by 2030 with a compound annual growth rate (CAGR) of 6.6%. This growth during the forecast period is attributed to the expansion of precision medicine and personalized nutrition, increased government support for biotech R&D, the scaling up of microbial and yeast expression systems, the adoption of AI and automation in production, and its growing application across cosmetics, cleaning products, and food industries. Significant trends during this period include advancements in synthetic biology, innovations in microbial engineering, the focus on cost-effective ingredient production, adherence to regulatory compliance and safety standards, and an expansion into food, personal care, and cleaning applications.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9817&type=smp

What Major Drivers Are Influencing Demand In The Biotech Ingredient Market?

The escalating need for personal care products is anticipated to drive the future expansion of the biotech ingredient market. Personal care products encompass a broad array of items used for maintaining personal cleanliness and enhancing one’s physical appearance. Biotech ingredients in these products offer benefits such as a reduced environmental footprint, enhanced sustainability, consistent quality, lower allergenic potential, biocompatibility, improved effectiveness, and decreased reliance on petrochemicals. For illustration, in December 2024, data from the Bureau of Labor Statistics, a US-based government agency, indicated that the average annual expenditure on personal care products and services saw an increase from $866 per consumer unit in 2022 to $950 per consumer unit in 2023. Hence, the rising consumer demand for personal care products is propelling the growth of the biotech ingredient market.

What Major Segment Divisions Exist Within The Biotech Ingredient Market?

The biotech ingredient market covered in this report is segmented –

1) By Type: Active Pharmaceutical Ingredients, Biosimilars

2) By Expression Systems: Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems, Insect Expression Systems

3) By Application: Food And Beverages, Personal Care And Cosmetics, Cleaning Products, Other Applications

Subsegments:

1) By Active Pharmaceutical Ingredients (APIs): Biologic APIs, Synthetic APIs

2) By Biosimilars: Monoclonal Antibodies, Recombinant Proteins, Insulin Biosimilars

How Are Trends Shaping The Direction Of The Biotech Ingredient Market?

Major companies in the biotech ingredient market are focused on creating innovative solutions, including advanced biotechnology-based ingredient platforms, to address the growing demand for high-performance, sustainable, and next-generation cosmetic and personal care formulations. These biotechnology-driven ingredients harness enzymatic and bio-based processes to generate novel molecular structures with enhanced functionality, delivering superior performance, scalability, and environmental benefits compared to traditional chemically synthesized ingredients. For instance, in March 2023, International Flavors & Fragrances Inc., a US-based manufacturer specializing in fragrance, biotech solutions, cosmetic energetics, and organic health ingredients, introduced Aurist AGC, a new biopolymer for hair care. This exemplifies the potential of the new DEB platform by leveraging IFF’s comprehensive biotechnology capabilities to ensure sustained and high-performance glamour solutions that can truly bring about change in the cosmeceutical industry. The ingredient itself employs IFF’s proprietary Designed Enzymatic Biopolymers (DEB) technology, an advanced biotechnology capable of producing novel bio-based polysaccharides with distinct structures and product features.

Which Companies Are Leading Innovation In The Biotech Ingredient Market?

Major companies operating in the biotech ingredient market are Merck & Co. Inc., Sanofi S.A., AbbVie Inc., International Flavors & Fragrance (IFF) Inc., Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan Inc., Boehringer Ingelheim International GmbH., AstraZeneca plc., Givaudan, Firmenich SA, Amyris Inc., Advanced BioTech, Sollice Biotech, Novocap S.A., Eli Lilly, Bristol-Myers Squibb Company, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Biogen Inc., Amgen Inc., Johnson & Johnson, Genentech Inc., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals Inc., Celgene Corporation, Gilead Sciences Inc., BioMarin Pharmaceutical Inc., Incyte Corporation, Seattle Genetics Inc., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Moderna Inc., Editas Medicine Inc., Intellia Therapeutics Inc., Sangamo Therapeutics Inc., Bluebird Bio Inc., Spark Therapeutics Inc.

Read the full biotech ingredient market report here:

https://www.thebusinessresearchcompany.com/report/biotech-ingredient-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Biotech Ingredient Market?

Europe was the largest region in the biotech ingredient market in 2025. Asia-Pacific is expected to be the fastest-growing region in the biotech ingredients market report during the forecast period. The regions covered in the biotech ingredient market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Biotech Ingredient Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9817&type=smp

Browse Through More Reports Similar to the Global Biotech Ingredient Market 2026, By The Business Research Company

Biotech Ingredient Market Report 2026

https://www.thebusinessresearchcompany.com/report/biotech-ingredient-global-market-report

Bioactive Ingredients Market Report 2026

https://www.thebusinessresearchcompany.com/report/bioactive-ingredients-global-market-report

Ingredients Market Report 2026

https://www.thebusinessresearchcompany.com/report/ingredients-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795